Diagnostic performance of LumiraDx SARS-CoV-2 rapid antigen test compared to PCR for diagnosis of COVID-19 in Liberia
Moses Badio, Christina Lindan, Kumblytee Johnson, Cavan Reilly, Julie Blie, Katy Shaw-Saliba, Tamba Fayiah, John McCullough, J. Tanu Duworko, Elizabeth Higgs, Jeffrey Martin, Lisa Hensley
doi: https://doi.org/10.1101/2023.08.01.23293521
Moses Badio
aPartnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia
bDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA
Christina Lindan
bDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA
Kumblytee Johnson
aPartnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia
Cavan Reilly
cDivision of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA
Julie Blie
aPartnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia
Katy Shaw-Saliba
dNational Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health, Bethesda, Maryland, USA
Tamba Fayiah
aPartnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia
John McCullough
eAdvanced BioMedical Laboratories, LLC, Cinnaminson, New Jersey, USA
J. Tanu Duworko
aPartnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia
Elizabeth Higgs
dNational Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health, Bethesda, Maryland, USA
Jeffrey Martin
bDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA
Lisa Hensley
dNational Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health, Bethesda, Maryland, USA
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted August 06, 2023.
Diagnostic performance of LumiraDx SARS-CoV-2 rapid antigen test compared to PCR for diagnosis of COVID-19 in Liberia
Moses Badio, Christina Lindan, Kumblytee Johnson, Cavan Reilly, Julie Blie, Katy Shaw-Saliba, Tamba Fayiah, John McCullough, J. Tanu Duworko, Elizabeth Higgs, Jeffrey Martin, Lisa Hensley
medRxiv 2023.08.01.23293521; doi: https://doi.org/10.1101/2023.08.01.23293521
Diagnostic performance of LumiraDx SARS-CoV-2 rapid antigen test compared to PCR for diagnosis of COVID-19 in Liberia
Moses Badio, Christina Lindan, Kumblytee Johnson, Cavan Reilly, Julie Blie, Katy Shaw-Saliba, Tamba Fayiah, John McCullough, J. Tanu Duworko, Elizabeth Higgs, Jeffrey Martin, Lisa Hensley
medRxiv 2023.08.01.23293521; doi: https://doi.org/10.1101/2023.08.01.23293521
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2969)
- Dermatology (253)
- Emergency Medicine (445)
- Epidemiology (12806)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4621)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2941)
- Health Policy (1073)
- Hematology (393)
- HIV/AIDS (932)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (475)
- Neurology (4408)
- Nursing (238)
- Nutrition (649)
- Oncology (2295)
- Ophthalmology (652)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (281)
- Palliative Medicine (84)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (502)
- Public and Global Health (7004)
- Radiology and Imaging (1544)
- Respiratory Medicine (921)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)